Podchaser Logo
Home
Unlocking Synergy: Exploring the Interaction Between LAG-3 and Other Immune Checkpoints

Unlocking Synergy: Exploring the Interaction Between LAG-3 and Other Immune Checkpoints

Released Friday, 26th April 2024
Good episode? Give it some love!
Unlocking Synergy: Exploring the Interaction Between LAG-3 and Other Immune Checkpoints

Unlocking Synergy: Exploring the Interaction Between LAG-3 and Other Immune Checkpoints

Unlocking Synergy: Exploring the Interaction Between LAG-3 and Other Immune Checkpoints

Unlocking Synergy: Exploring the Interaction Between LAG-3 and Other Immune Checkpoints

Friday, 26th April 2024
Good episode? Give it some love!
Rate Episode

Host: Hussein Tawbi, MD, PhD

This activity focuses on improving clinician awareness and knowledge of LAG-3-based immunotherapy in metastatic melanoma. We aim to identify patients with metastatic melanoma who can benefit from LAG-3/PD-1 combination therapy and enhance the competence of the multidisciplinary team in managing these patients.

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features